Sodium Supplementation for Premature Birth
Trial Summary
What is the purpose of this trial?
The purpose of this project is to determine the direct impact of sodium supplementation in preterm infants and to see the overall improvement of their growth and health status. from this study will help us develop a better treatment for in the future.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it mentions that infants using diuretics (medications that help remove excess fluid) at the start of the study may need to wait or be re-evaluated.
What data supports the effectiveness of sodium supplementation as a treatment for premature birth?
Research shows that sodium supplementation in very low birth weight preterm infants can significantly improve growth rates, such as weight, length, and head circumference, without causing harmful sodium imbalances. This suggests that sodium supplementation may help support healthy development in premature infants.12345
Is sodium supplementation safe for premature infants?
Sodium supplementation in premature infants appears to be generally safe, with studies showing no significant adverse effects like hypernatremia (high sodium levels) or renal failure. It can improve growth and biochemical status without causing undesirable side effects, although careful monitoring is necessary to avoid complications.12356
How does sodium supplementation differ from other treatments for premature birth?
Sodium supplementation for premature infants is unique because it specifically addresses sodium deficiency, which is common in these infants due to high renal sodium losses. This treatment improves growth and biochemical status without causing undesirable side effects, unlike other treatments that may not target sodium balance directly.12567
Research Team
Jeffrey Segar, MD
Principal Investigator
Medical College of Wisconsin
Eligibility Criteria
This trial is for preterm infants with a birth weight over 500 grams, born between 25 and less than 30 weeks of gestation, and who are younger than 14 days old at the time they join. Infants with major birth defects, kidney problems indicated by high creatinine levels, or those on diuretics can't participate unless their condition stabilizes.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized into two groups: one receiving sodium supplementation based on a urine sodium concentration algorithm, and the other managed by current standards. Nutritional and health data are collected.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including microbiome diversity and weight gain.
Treatment Details
Interventions
- Sodium algorithm
Sodium algorithm is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
- Hyponatremia correction
- Fluid resuscitation
- Electrolyte imbalance
- Hyponatremia correction
- Fluid resuscitation
- Electrolyte imbalance
- Hyponatremia correction
- Fluid resuscitation
- Electrolyte imbalance
- Hyponatremia correction
- Fluid resuscitation
- Electrolyte imbalance
- Hyponatremia correction
- Fluid resuscitation
- Electrolyte imbalance
- Hyponatremia correction
- Fluid resuscitation
- Electrolyte imbalance
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical College of Wisconsin
Lead Sponsor